LVW Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
LVW Advisors's ASND Position: Q3 2026 in Review
LVW Advisors sold out of Ascendis Pharma (ASND) in Q3 2026, closing a stake of 946 shares — an estimated $253K sold.
LVW Advisors first reported a position in ASND in Q2 2025 and held it in 5 quarters. The position peaked at $253K in Q2 2026. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- LVW Advisors reported no remaining Ascendis Pharma position as of Q3 2026 after selling out during the quarter.
- LVW Advisors sold 946 Ascendis Pharma shares in Q3 2026, an estimated $253K.
- LVW Advisors first reported a position in Ascendis Pharma in Q2 2025 and held it in 5 quarters.
- LVW Advisors's Ascendis Pharma position peaked at $253K in Q2 2026.
- 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on LVW Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.